Indaptus Therapeutics, Inc. — Form D

Indaptus Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-06. The offering totals $227K, of which $227K was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2024-12-06
Form: D
Accession: 0001857044-24-000003
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $227K
Amount sold: $227K
Investors: 20
Date of first sale: 2024-11-22
Revenue range: Decline to Disclose
SEC file number: 021-531407

Issuer

Name: Indaptus Therapeutics, Inc.
CIK: 0001857044
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 3 COLUMBUS CIRCLE, NEW YORK, NY, 10019
Phone: (646) 427-2727

Officers, directors & promoters (19)

Name	Role	Location
Anthony J Maddaluna	Director	New York, NY
Hila J Karah	Director	New York, NY
Robert E Martell	Director	New York, NY
Roger J Pomerantz	Director	New York, NY
William B Hayes	Director	New York, NY
Roger J Waltzman	Executive Officer	New York, NY
Michael J Newman	Director	New York, NY
Michael J Newman	Executive Officer	New York, NY
Nir J Sassi	Executive Officer	New York, NY
MARK J GILBERT	Director	NEW YORK, NY
NIR A SASSI	Executive Officer	NEW YORK, NY
WALT A LINSCOTT	Executive Officer	NEW YORK, NY
HOONMO A LEE	Director	NEW YORK, NY
MICHAEL A NEWMAN	Director	NEW YORK, NY
MICHAEL A NEWMAN	Executive Officer	NEW YORK, NY
HILA W KARAH	Director	NEW YORK, NY
BRIAN J O'CALLAGHAN	Director	NEW YORK, NY
JEFFREY A MECKLER	Director	TUCKER, GA
JEFFREY A MECKLER	Executive Officer	TUCKER, GA

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2025-06-20	D	$5.0M	$2.3M
2025-01-22	D	$2.2M	$2.2M
2024-10-04	D/A	$205K	$205K
2024-08-22	D	$205K	$205K
2021-08-05	D	$30.0M	$30.0M

More